World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
36643
World Ranking
9993
National Ranking
141

Overview

Dolors Colomer is affiliated with the University of Barcelona in Spain. Their research primarily spans the field of Medicine, with a focus on several subfields including Genetics, Pathology and Forensic Medicine, Immunology, Molecular Biology, and Oncology.

The scientist's work covers various main topics such as:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Frequent publication venues for Dolors Colomer include:

  • Blood
  • Leukemia
  • HemaSphere
  • Blood Advances
  • Cancers

Some of the recent papers where Dolors Colomer is a co-author include:

  • Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes (2020, Blood)
  • Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation (2021, Nature Communications)
  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia (2022, Nature Medicine)
  • Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity (2021, Immunity)
  • An atlas of cells in the human tonsil (2024, Immunity)

Frequent co-authors associated with Dolors Colomer include:

  • Elías Campo
  • Mònica López-Guerra
  • Sílvia Beà
  • Ferran Nadeu
  • José I. Martín-Subero

Best Publications

  • Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Mario F Fraga;Esteban Ballestar;Ana Villar-Garea;Manuel Boix-Chornet

  • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde

  • ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

    Marta Crespo;Francesc Bosch;Neus Villamor;Beatriz Bellosillo

  • Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

    Víctor Quesada;Laura Conde;Neus Villamor;Gonzalo R Ordóñez

  • Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Silvia Beà;Rafael Valdés-Mas;Neus Villamor

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.

    Sílvia Beà;Frederic Tort;Magda Pinyol;Xavier Puig

  • Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

    Marta Kulis;Simon Heath;Marina Bibikova;Ana C Queirós

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

    Miguel A. Sanz;Guillermo Martín;Marcos González;Angel León

  • Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

    Pedro Jares;Dolors Colomer;Elias Campo

  • Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

    Lluı́s Colomo;Armando López-Guillermo;Armando López-Guillermo;Marı́a Perales;Marı́a Perales;Susana Rives;Susana Rives

  • A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

    Miguel A. Sanz;Guillermo Martı́n;Consuelo Rayón;Jordi Esteve

  • The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

    Patricia Pérez-Galán;Gaël Roué;Neus Villamor;Emili Montserrat

  • Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Sílvia Beà;Rafael Valdés-Mas;Alba Navarro;Itziar Salaverria

  • Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

    Verònica Fernàndez;Olga Salamero;Blanca Espinet;Francesc Solé

  • International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

    A C Rawstron;N Villamor;M Ritgen;S Böttcher

  • Molecular pathogenesis of mantle cell lymphoma

    Pedro Jares;Dolors Colomer;Elias Campo

  • SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

    Ana Mozos;Cristina Royo;Elena Hartmann;Daphne De Jong

  • Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

    Elisa Rumi;Daniela Pietra;Cristiana Pascutto;Paola Guglielmelli

  • Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin

    Armando López-Guillermo;Luis Colomo;Mónica Jiménez;Francesc Bosch

Frequent Co-Authors

Elias Campo
Elias Campo University of Barcelona
Neus Villamor
Neus Villamor University of Barcelona
Emili Montserrat
Emili Montserrat University of Barcelona
Armando López-Guillermo
Armando López-Guillermo University of Barcelona
Sílvia Beà
Sílvia Beà University of Barcelona
Francisco Cervantes
Francisco Cervantes University of Barcelona
Itziar Salaverria
Itziar Salaverria University of Barcelona
Xose S. Puente
Xose S. Puente University of Oviedo
Marcos González
Marcos González University of Salamanca
Carlos López-Otín
Carlos López-Otín University of Oviedo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens the door to various online degree programs and specialized pathways. If you’re seeking healthcare leadership, consider cahme accredited mha online programs, which ensure your master’s in health administration meets rigorous industry standards.

Registered nurses looking to advance can now find flexible study options. For instance, there are rn to bsn without clinicals, making it easier for working nurses to earn their bachelor’s degree fully online without in-person clinical requirements.

For nurses aiming for top clinical qualifications, online Doctor of Nursing Practice programs can offer both convenience and speed. Some options focus on efficiency, like the shortest msn to dnp program, helping you progress quickly from a master’s to doctorate level. Others are designed for accessibility and ease, as seen in the easiest online dnp programs which prioritize user-friendly curricula and flexible scheduling.

Online medical and healthcare degrees allow you to tailor your education to fit your career goals, time frame, and lifestyle, making the pursuit of advanced roles in healthcare more accessible than ever.

Best Scientists Citing Dolors Colomer

Trending Scientists

Recently Published Articles